Home›Companies›Healthcare›CoreMap

CoreMap, Inc.

Develops heart rhythm mapping technology for doctors treating atrial fibrillation.

Updated Nov 10, 2026·Latest SEC filing Jun 24, 2026·Suggest an edit

About CoreMap

CoreMap is a private company based in Burlington, Massachusetts. It has reported $75,288,606 raised in six offerings on Form D since September 2017. Its chief executive is Sarah Kalil.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 18, 2026Jun 24, 2026$35,509,826of $45.0M target73$486KEquityRule 506(b)Form D ↗
Jul 24, 2024Jul 14, 2025$6,817,466of $30.0M target19$358KSecurities on exerciseRule 506(b)Form D ↗
Jan 27, 2022Feb 8, 2022$23,249,971of $27.9M target26$894KEquityRule 506(b)Form D ↗
Sep 9, 2020Sep 24, 2020$8,911,343fully sold18$495KEquityRule 506(b)Form D ↗
Apr 17, 2019May 2, 2019$500,000of $750K target3$166KConvertible DebtRule 506(b)Form D ↗
Sep 25, 2017Sep 25, 2017$300,000of $500K target3$100KConvertible debtRule 506(b)Form D ↗
Total, six offerings$75,288,606

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on CoreMap's Form D filed Jun 24, 2026.

SK
Sarah Kalil
Co-Founder, President, and CEO, director
GR
Gowri Raman
Director
AK
Allen Kamer
Director
AR

Earlier filings also listed Peter Spector (chief scientific officer and director, last listed Jul 2025), Ronny Ginor (director, last listed Sep 2020) and William Gruber (director, last listed May 2019).

Sources

  1. SECCoreMap, Inc. filing history
  2. CompanyCoreMap Series A announcement